West Pharmaceutical Services (WST) Tax Provisions (2009 - 2026)

West Pharmaceutical Services' Tax Provisions history runs 18 years deep, the most recent figure standing at $44.7 million for Q1 2026.

• In Q1 2026, Tax Provisions rose 85.48% year-over-year to $44.7 million; the TTM figure through Mar 2026 stood at $142.2 million (up 23.44% YoY), while the FY2025 annual figure was $121.6 million, up 13.12% from the prior year.
• Tax Provisions came in at $44.7 million for Q1 2026 at West Pharmaceutical Services, up from $33.3 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $44.7 million in Q1 2026 to a low of $16.4 million in Q1 2024.
• A 5-year average of $30.0 million and a median of $30.2 million in 2025 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions sank 37.07% in 2024 and soared 85.48% in 2026, its largest moves.
• West Pharmaceutical Services' Tax Provisions stood at $28.9 million in 2022, then rose by 19.38% to $34.5 million in 2023, then gained by 6.67% to $36.8 million in 2024, then declined by 9.51% to $33.3 million in 2025, then soared by 34.23% to $44.7 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $44.7 million, $33.3 million, and $34.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison